BIO — Biotest Gmbh and Co. KgaA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSucker Stock

Annual balance sheet for Biotest Gmbh and Co. KgaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	118	144	108	108	89.8
Net Total Accounts Receivable
Net Total Receivables	151	164	205	201	227
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	522	619	757	810	874
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	550	548	578	571	556
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,104	1,203	1,411	1,434	1,530
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	106	130	385	160	155
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	724	832	912	903	1,066
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	380	371	499	531	464
Total Liabilities & Shareholders' Equity	1,104	1,203	1,411	1,434	1,530
Total Common Shares Outstanding